Follow the people · Insider
John Kiely
John Kiely files insider transactions with the SEC as a director of Amneal Pharmaceuticals (AMRX). We hold 1 disclosed purchase or sale filed since 17 December 2019, 1 of them in the last 90 days.
- Files forAMRX
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure14 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 14 December 2019 — 13 August 2026Director · Amneal Pharmaceuticals (AMRX)31 Form 4 lines · source: SEC Form 4
- Filed 31 August 2019 — 31 August 2022Director · Zovio (ZVO)15 Form 4 lines · source: SEC Form 4
Everything they disclosed
46 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 50,000 shares of Amneal PharmaceuticalsSEC Form 414 August 2026Class A Common Stock · traded 13 August 2026 · filed 14 August 2026
- gave away 10,000 shares of Amneal PharmaceuticalsSEC Form 414 August 2026Class A Common Stock · traded 13 August 2026 · filed 14 August 2026
- exercised options over 34,819 shares of Amneal PharmaceuticalsSEC Form 48 May 2026Class A Common Stock · traded 7 May 2026 · filed 8 May 2026
- exercised options over 34,819 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 48 May 2026Restricted Stock Units · traded 7 May 2026 · filed 8 May 2026
- was granted 19,824 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 48 May 2026Restricted Stock Units · traded 6 May 2026 · filed 8 May 2026
- ▼ sold on the open market 32,000 shares of Amneal PharmaceuticalsSEC Form 428 August 2025Class A Common Stock · traded 27 August 2025 · filed 28 August 2025
- ▼ sold on the open market 50,000 shares of Amneal PharmaceuticalsSEC Form 413 May 2025Class A Common Stock · traded 12 May 2025 · filed 13 May 2025
- exercised options over 40,258 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 48 May 2025Restricted Stock Units · traded 5 May 2025 · filed 8 May 2025
- was granted 34,819 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 48 May 2025Restricted Stock Units · traded 6 May 2025 · filed 8 May 2025
- exercised options over 40,258 shares of Amneal PharmaceuticalsSEC Form 48 May 2025Class A Common Stock · traded 5 May 2025 · filed 8 May 2025
- exercised options over 28,506 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 426 November 2024Stock Option · traded 22 November 2024 · filed 26 November 2024
- exercised options over 28,506 shares of Amneal PharmaceuticalsSEC Form 426 November 2024Class A Common Stock · traded 22 November 2024 · filed 26 November 2024
- ▼ sold on the open market 17,058 shares of Amneal PharmaceuticalsSEC Form 426 November 2024Class A Common Stock · traded 22 November 2024 · filed 26 November 2024
- exercised options over 76,453 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 414 May 2024Restricted Stock Units · traded 10 May 2024 · filed 14 May 2024
- exercised options over 76,453 shares of Amneal PharmaceuticalsSEC Form 414 May 2024Class A Common Stock · traded 10 May 2024 · filed 14 May 2024
- was granted 40,258 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 46 May 2024Restricted Stock Units · traded 2 May 2024 · filed 6 May 2024
- was granted 76,453 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 411 May 2023Restricted Stock Units · traded 9 May 2023 · filed 11 May 2023
- exercised options over 80,128 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 411 May 2023Restricted Stock Units · traded 10 May 2023 · filed 11 May 2023
- exercised options over 80,128 shares of Amneal PharmaceuticalsSEC Form 411 May 2023Class A Common Stock · traded 10 May 2023 · filed 11 May 2023
- exercised options over 8,855 shares of Zovio (a derivative holding)SEC Form 42 September 2022Restricted Stock Units · traded 31 August 2022 · filed 2 September 2022
- exercised options over 8,855 shares of ZovioSEC Form 42 September 2022Common Stock · traded 31 August 2022 · filed 2 September 2022
- exercised options over 35,406 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 410 May 2022Restricted Stock Units · traded 8 May 2022 · filed 10 May 2022
- was granted 80,128 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 410 May 2022Restricted Stock Units · traded 9 May 2022 · filed 10 May 2022
- exercised options over 35,406 shares of Amneal PharmaceuticalsSEC Form 410 May 2022Class A Common Stock · traded 8 May 2022 · filed 10 May 2022
- exercised options over 16,410 shares of Zovio (a derivative holding)SEC Form 431 March 2022Restricted Stock Unit · traded 29 March 2022 · filed 31 March 2022
- was granted 18,890 shares of Zovio (a derivative holding)SEC Form 431 March 2022Restricted Stock Unit · traded 29 March 2022 · filed 31 March 2022
- exercised options over 16,410 shares of ZovioSEC Form 431 March 2022Common Stock · traded 29 March 2022 · filed 31 March 2022
- exercised options over 8,855 shares of Zovio (a derivative holding)SEC Form 42 September 2021Restricted Stock Units · traded 31 August 2021 · filed 2 September 2021
- exercised options over 8,855 shares of ZovioSEC Form 42 September 2021Common Stock · traded 31 August 2021 · filed 2 September 2021
- was granted 35,406 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 47 May 2021Restricted Stock Units · traded 5 May 2021 · filed 7 May 2021
- exercised options over 46,218 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 47 May 2021Restricted Stock Units · traded 6 May 2021 · filed 7 May 2021
- exercised options over 46,218 shares of Amneal PharmaceuticalsSEC Form 47 May 2021Class A Common Stock · traded 6 May 2021 · filed 7 May 2021
- exercised options over 18,890 shares of ZovioSEC Form 431 March 2021Common Stock · traded 29 March 2021 · filed 31 March 2021
- exercised options over 18,890 shares of Zovio (a derivative holding)SEC Form 431 March 2021Restricted Stock Unit · traded 29 March 2021 · filed 31 March 2021
- was granted 16,410 shares of Zovio (a derivative holding)SEC Form 431 March 2021Restricted Stock Unit · traded 29 March 2021 · filed 31 March 2021
- exercised options over 7,522 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 418 December 2020Restricted Stock Units · traded 15 December 2020 · filed 18 December 2020
- exercised options over 7,522 shares of Amneal PharmaceuticalsSEC Form 418 December 2020Class A Common Stock · traded 15 December 2020 · filed 18 December 2020
- ▲ bought on the open market 10,000 shares of ZovioSEC Form 410 September 2020Common Stock · traded 8 September 2020 · filed 10 September 2020
- exercised options over 8,855 shares of Zovio (a derivative holding)SEC Form 41 September 2020Restricted Stock Units · traded 31 August 2020 · filed 1 September 2020
- exercised options over 8,855 shares of ZovioSEC Form 41 September 2020Common Stock · traded 31 August 2020 · filed 1 September 2020
- ▲ bought on the open market 10,000 shares of Amneal PharmaceuticalsSEC Form 419 May 2020Class A Common Stock · traded 19 May 2020 · filed 19 May 2020
- was granted 18,890 shares of Zovio (a derivative holding)SEC Form 414 May 2020Restricted Stock Unit · traded 12 May 2020 · filed 14 May 2020
- was granted 46,218 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 46 May 2020Restricted Stock Units · traded 5 May 2020 · filed 6 May 2020
- was granted 35,420 shares of Zovio (a derivative holding)SEC Form 49 January 2020Restricted Stock Unit · traded 31 August 2019 · filed 9 January 2020
- was granted 28,506 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 417 December 2019Stock Option · traded 14 December 2019 · filed 17 December 2019
- was granted 7,522 shares of Amneal Pharmaceuticals (a derivative holding)SEC Form 417 December 2019Restricted Stock Units · traded 14 December 2019 · filed 17 December 2019
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.